Table 2.
Total prevalence and diagnosis of chronic conditions by education group (%)
| Total | Education |
||||
|---|---|---|---|---|---|
| Low | Mid | High | |||
| Diabetes | Prevalence | ||||
| Objective or medication* | 9.8 (9.0-10.6) | 15.2 (13.5-16.8) | 11.6 (10.1-13.1) [3.1] | 7.5 (6.7-8.4) [7.9] | |
| Self-report | 7.7 (7.0-8.4) | 12.3 (10.6-13.9) | 8.5 (7.1-9.9) [3.5] | 6.1 (5.3-6.8) [6.8] | |
| Objective | 7.6 (6.9-8.3) | 12.1 (10.7-13.6) | 9.0 (7.6-10.3) [3.1] | 5.7 (4.9-6.5) [7.8] | |
| Medication | 6.4 (5.7-7.0) | 10.3 (8.9-11.7) | 7.0 (5.7-8.3) [3.4] | 5.0 (4.2-5.7) [6.7] | |
| Within Prevalence (n=1,434) | |||||
| Diagnosed | 70.0 (66.7-73.3) | 72.6 (68.3-76.8) | 64.8 (58.0-71.7) [1.8] | 71.7 (66.3-77.1) [0.3] | |
| Taking Medication | 65.0 (61.4-68.6) | 67.8 (63.3-72.3) | 60.4 (53.4-67.4) [1.7] | 66.1 (60.3-72.0) [0.5] | |
|
| |||||
| Hypertension | Prevalence | ||||
| Objective or medication* | 30.1 (29.1-31.1) | 36.2 (34.4-38.1) | 33.8 (32.1-35.4) [2.0] | 26.9 (25.7-28.1) [9.1] | |
| Self-report | 29.8 (28.8-30.8) | 35.1 (33.3-36.8) | 32.5 (31.0-34.1) [2.6] | 27.2 (26.0-28.5) [7.9] | |
| Objective | 15.4 (14.7-16.1) | 20.6 (19.1-22.1) | 17.4 (16.2-18.7) [3.4] | 13.2 (12.3-14.1) [8.5] | |
| Medication | 21.1 (20.2-22.0) | 25.2 (23.5-26.8) | 23.1 (21.8-24.5) [2.0] | 19.2 (18.0-20.4) [6.6] | |
| Within Prevalence (n=6,976) | |||||
| Diagnosed | 79.0 (77.5-80.4) | 79.4 (77.1-81.6) | 78.1 (75.6-80.6) [0.9] | 79.2 (77.1-81.3) [0.1] | |
| Taking Medication | 70.2 (68.4-72.0) | 69.5 (66.6-72.4) | 68.5 (66.0-71.0) [0.6] | 71.3 (68.8-73.8) [−1.0] | |
|
| |||||
| High Cholesterol |
Prevalence | ||||
| Objective or medication* | 28.6 (27.7-29.4) | 30.5 (28.8-32.2) | 31.4 (29.8-33.0) [−0.8] | 26.9 (25.7-28.1) [3.6] | |
| Self-report | 31.3 (30.4-32.3) | 29.9 (28.3-31.6) | 32.5 (30.7-34.2) [−2.2] | 31.3 (30.1-32.5) [−1.5] | |
| Objective | 16.4 (15.7-17.2) | 17.7 (16.3-19.0) | 18.2 (16.9-19.5) [−0.6] | 15.4 (14.5-16.4) [2.6] | |
| Medication | 14.0 (13.2-14.7) | 15.8 (14.3-17.2) | 15.2 (14.1-16.3) [0.7] | 12.9 (12.0-13.9) [3.4] | |
| Within Prevalence (n=6,987) | |||||
| Diagnosed | 71.6 (70.0-73.2) | 68.0 (65.3-70.8) | 70.6 (67.9-73.3) [−1.4] | 73.2 (70.9-75.6) [−3.0] | |
| Taking Medication | 48.9 (47.0-50.8) | 51.7 (48.4-54.9) | 48.3 (45.6-51.1) [1.8] | 48.2 (45.5-50.9) [1.6] | |
Notes:
*
Total prevalence. 95% CI is in parentheses. T-test statistics are shown in squared brackets. T-tests conducted to test for differences between mid education group and low education group, and for differences between high education group and low education group. Statistics are weighted. “Within prevalence” indicates that the sample is limited to respondents who are in the total prevalence group, meaning that they have the disease based on objective measurement or self-report medication for the disease.